A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here is one cash-producing company that reinvests wisely to drive long-term success and two best left off your watchlist.
Two Stocks to Sell:
Benchmark (BHE)
Trailing 12-Month Free Cash Flow Margin: 3.7%
Operating as a critical behind-the-scenes partner for complex technology products since 1979, Benchmark Electronics (NYSE: BHE) provides advanced manufacturing, engineering, and technology solutions for original equipment manufacturers across aerospace, medical, industrial, and technology sectors.
Why Does BHE Fall Short?
- Customers postponed purchases of its products and services this cycle as its revenue declined by 3.2% annually over the last two years
- Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital
- ROIC of 7.2% reflects management’s challenges in identifying attractive investment opportunities
Benchmark’s stock price of $53.54 implies a valuation ratio of 21.9x forward P/E. Dive into our free research report to see why there are better opportunities than BHE.
AdaptHealth (AHCO)
Trailing 12-Month Free Cash Flow Margin: 6.8%
With a network of approximately 680 locations serving patients across all 50 states, AdaptHealth (NASDAQ: AHCO) provides home medical equipment, supplies, and related services to patients with chronic conditions like sleep apnea, diabetes, and respiratory disorders.
Why Is AHCO Not Exciting?
- Products and services are facing end-market challenges during this cycle, as seen in its flat sales over the last two years
- Earnings per share fell by 6.4% annually over the last five years while its revenue grew, partly because it diluted shareholders
- Below-average returns on capital indicate management struggled to find compelling investment opportunities
AdaptHealth is trading at $11.37 per share, or 11.2x forward P/E. To fully understand why you should be careful with AHCO, check out our full research report (it’s free).
One Stock to Buy:
Sea (SE)
Trailing 12-Month Free Cash Flow Margin: 21.4%
Founded in 2009 and a publicly traded company since 2017, Sea (NYSE: SE) started as a gaming platform and has since expanded to offer a variety of services such as e-commerce, digital payments, and financial services across Southeast Asia.
Why Will SE Outperform?
- Paying Users are rising, meaning the company can increase revenue without incurring additional customer acquisition costs if it can cross-sell additional products and features
- Incremental sales significantly boosted profitability as its annual earnings per share growth of 60.9% over the last three years outstripped its revenue performance
- Free cash flow margin jumped by 30.7 percentage points over the last few years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
At $78.11 per share, Sea trades at 11.5x forward EV/EBITDA. Is now the time to initiate a position? Find out in our full research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
